Innovation Conversation Posted August 28 Share Posted August 28 Luis Valente , CEO of ILOF, discusses the challenges and opportunities in scaling personalized healthcare. ILOF is a deep tech health tech company that collects and processes large amounts of data to identify the right patients for clinical studies. The goal is to bring personalized medicine to the masses by selecting the most effective treatments for individual patients. Valente shares insights on starting a deep tech startup, the importance of creating goodwill, and the differences between the US and European markets. He also discusses the limitations of their solution and the future of personalized medicine.Chapters00:00Introduction and Background01:02Falling in Love with the Problem03:14Starting a Deep Tech Startup04:33Considerations for Building a Company in the US07:26Creating Goodwill and Building a Team10:11Challenges in the Early Stages12:01Recognition and Achievements13:47The Process and Impact of ILOF's Solution15:35The Future of Personalized Medicine20:35US Market vs. European Market24:10Raising Capital in the US26:17Building a Company in the US: When and Why27:07ConclusionListen In Quote Link to comment Share on other sites More sharing options...
.png.c88dcc332c18e894b884a26543b3aa34.png)
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.